Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 CAD | -51.61% |
|
-51.61% | -25.00% |
Business Summary
Number of employees: 1
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 30/06/19 |
Soo-Whan Kim
DFI | Director of Finance/CFO | - | 06/01/23 |
Andrew Hegle
BRD | Director/Board Member | 46 | 31/12/19 |
Joseph Cullen
IRC | Investor Relations Contact | 41 | 30/04/19 |
Kelly Pladson
SEC | Corporate Secretary | 42 | - |
Jonna Birgans
PRN | Corporate Officer/Principal | - | 03/02/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Ko
CEO | Chief Executive Officer | 39 | 30/06/19 |
Andrew Hegle
BRD | Director/Board Member | 46 | 31/12/19 |
Director/Board Member | 53 | 04/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,858,926 | 8,668,934 ( 97.86 %) | 0 | 97.86 % |
Company contact information
Entheon Biomedical Corp.
999 West Broadway Suite 720
V5Z 1K5, Vancouver
+
http://www.entheonbiomedical.com![address Entheon Biomedical Corp.(ENBI)](https://cdn.zonebourse.com/static/address/43256782.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-25.00% | 487K | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ENBI Stock
- Company Entheon Biomedical Corp.